Amgen, Inc. (AMGN)
353.87
+0.71
(+0.20%)
USD |
NASDAQ |
Mar 27, 10:11
Amgen Market Cap : 190.76B for March 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 27.70B |
| Gilead Sciences, Inc. | 170.35B |
| Johnson & Johnson | 582.81B |
| Eli Lilly & Co. | 795.11B |
| Regeneron Pharmaceuticals, Inc. | 79.48B |
Market Cap Related Metrics
| PE Ratio | 24.86 |
| PS Ratio | 5.218 |
| PEG Ratio | 0.2806 |
| Price to Book Value | 22.03 |
| Price to Free Cash Flow | 23.67 |
| Price | 353.87 |
| Earnings Yield | 4.02% |
| PEGY Ratio | 0.2721 |
| Operating PE Ratio | 18.68 |
| Normalized PE Ratio | 22.51 |